Quest Diagnostics Inc
DGX: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| ?!& | LOCK|$TTN | LOCK|>>nC!@> |
Quest Diagnostics Earnings: Outsize Revenue Growth Boosted by Acquisitions Should Linger Into 2025
Quest Diagnostics posted strong third-quarter results, with an assist from acquisitions that boosted quarterly volume growth to 5.5% year over year.
